Skip to main content
PMC home page
Gut logoLink to Gut
. 1998 Jan;42(1):107–111. doi: 10.1136/gut.42.1.107

Hepatitis G virus infection in chronic liver disease

M Guilera 1, J Saiz 1, F Lopez-Labrador 1, E Olmedo 1, S Ampurdanes 1, X Forns 1, J Bruix 1, A Pares 1, J Sanchez-Tapias 1, M T J de Anta 1, J Rodes 1
PMCID: PMC1726956  PMID: 9505895

Abstract

Background—The hepatitis G virus (HGV), a recently identified member of the Flaviviridae family, can cause chronic infection in man but the role of this agent in chronic liver disease is poorly understood. 
Aims—To evaluate the prevalence and meaning of HGV infection in a large series of patients with chronic liver disease. 
Subjects—Two hundred volunteer blood donors, 179 patients with chronic hepatitis C, 111 with chronic hepatitis B, 104 with alcoholic liver disease, 136 with hepatocellular carcinoma, and 24 with cryptogenic chronic liver disease were studied. 
Methods—HGV RNA was investigated in serum samples by reverse transcription and polymerase chain reaction amplification of the 5' non-coding region of HCV and hybridisation to a specific probe. The main features of HGV RNA seropositive and seronegative patients were compared. 
Results—The prevalence of HGV infection was 3% in blood donors, 7% in chronic hepatitis C, 8% in chronic hepatitis B, 2% in alcoholic liver disease, 4% in hepatocellular carcinoma, and 8% in cryptogenic chronic liver disease. HGV infected patients tended to be younger than non-infected patients but no differences concerning sex, possible source of infection, clinical manifestations, biochemical and virological parameters, or severity of liver lesions were found. 
Conclusions—The prevalence of HGV infection in chronic liver disease seems to be relatively low in our area. Infection with HGV does not seem to play a significant pathogenic role in patients with chronic liver disease related to chronic HBV or HCV infection or to increased alcohol consumption, or in those with cryptogenic chronic liver disease. 



Keywords: chronic liver disease; hepatitis G virus

Full Text

The Full Text of this article is available as a PDF (106.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa T., Sugai Y., Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 1996 Jan 18;334(3):195–196. doi: 10.1056/NEJM199601183340316. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J., Nakatsuji Y., Melpolder J., Wages J., Wesley R., Shih J. W., Kim J. P. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 1997 Mar 13;336(11):747–754. doi: 10.1056/NEJM199703133361102. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Gallagher M., Morris T. T., Moyer L. A., Meeks E. L., Krawczynski K., Kim J. P., Margolis H. S. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997 Mar 13;336(11):741–746. doi: 10.1056/NEJM199703133361101. [DOI] [PubMed] [Google Scholar]
  4. Belli L. S., Idéo G., Silini E. Hepatitis G virus and post-transplantation hepatitis. N Engl J Med. 1996 Oct 31;335(18):1394–1395. doi: 10.1056/NEJM199610313351812. [DOI] [PubMed] [Google Scholar]
  5. Berg T., Dirla U., Naumann U., Heuft H. G., Küther S., Lobeck H., Schreier E., Hopf U. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol. 1996 Nov;25(5):763–768. doi: 10.1016/s0168-8278(96)80250-9. [DOI] [PubMed] [Google Scholar]
  6. Costa J., López-Labrador F. X., Sánchez-Tapias J. M., Mas A., Vilella A., Olmedo E., Vidal J., Jimenez de Anta M. T., Rodés J. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol. 1995 Jan;22(1):35–42. doi: 10.1016/0168-8278(95)80257-6. [DOI] [PubMed] [Google Scholar]
  7. Fiordalisi G., Zanella I., Mantero G., Bettinardi A., Stellini R., Paraninfo G., Cadeo G., Primi D. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis. 1996 Jul;174(1):181–183. doi: 10.1093/infdis/174.1.181. [DOI] [PubMed] [Google Scholar]
  8. Forns X., Fernández-Llama P., Costa J., López-Labrador F. X., Ampurdanés S., Olmedo E., Saiz J. C., Guilera M., López-Pedret J., Sánchez-Tapias J. M. Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant. 1997 May;12(5):956–960. doi: 10.1093/ndt/12.5.956. [DOI] [PubMed] [Google Scholar]
  9. Forns X., Maluenda M. D., López-Labrador F. X., Ampurdanès S., Olmedo E., Costa J., Simmonds P., Sánchez-Tapias J. M., Jimenez De Anta M. T., Rodés J. Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol. 1996 Oct;34(10):2516–2521. doi: 10.1128/jcm.34.10.2516-2521.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heringlake S., Osterkamp S., Trautwein C., Tillmann H. L., Böker K., Muerhoff S., Mushahwar I. K., Hunsmann G., Manns M. P. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 1996 Dec 14;348(9042):1626–1629. doi: 10.1016/S0140-6736(96)04413-3. [DOI] [PubMed] [Google Scholar]
  11. Hillaire S., Ballet F., Franco D., Setchell K. D., Poupon R. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hepatology. 1995 Jul;22(1):82–87. [PubMed] [Google Scholar]
  12. Jarvis L. M., Davidson F., Hanley J. P., Yap P. L., Ludlam C. A., Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet. 1996 Nov 16;348(9038):1352–1355. doi: 10.1016/s0140-6736(96)04041-x. [DOI] [PubMed] [Google Scholar]
  13. Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
  14. Masuko K., Mitsui T., Iwano K., Yamazaki C., Okuda K., Meguro T., Murayama N., Inoue T., Tsuda F., Okamoto H. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 1996 Jun 6;334(23):1485–1490. doi: 10.1056/NEJM199606063342301. [DOI] [PubMed] [Google Scholar]
  15. Okamoto H., Sugiyama Y., Okada S., Kurai K., Akahane Y., Sugai Y., Tanaka T., Sato K., Tsuda F., Miyakawa Y. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992 Mar;73(Pt 3):673–679. doi: 10.1099/0022-1317-73-3-673. [DOI] [PubMed] [Google Scholar]
  16. Sampietro M., Badalamenti S., Graziani G., Como G., Buccianti G., Corbetta N., Ticozzi A., Archenti A., Lunghi G., Penso D. Hepatitis G virus infection in hemodialysis patients. Kidney Int. 1997 Jan;51(1):348–352. doi: 10.1038/ki.1997.43. [DOI] [PubMed] [Google Scholar]
  17. Schmidt B., Korn K., Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet. 1996 Mar 30;347(9005):909–909. doi: 10.1016/s0140-6736(96)91396-3. [DOI] [PubMed] [Google Scholar]
  18. Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995 Jun;1(6):564–569. doi: 10.1038/nm0695-564. [DOI] [PubMed] [Google Scholar]
  19. Stark K., Bienzle U., Hess G., Engel A. M., Hegenscheid B., Schluter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis. 1996 Dec;174(6):1320–1323. doi: 10.1093/infdis/174.6.1320. [DOI] [PubMed] [Google Scholar]
  20. Sáiz J. C., Ampurdanés S., Olmedo E., López-Labrador F. X., Forns X., Guilera M., Tassies D., Costa J., Sánchez-Tapias J. M., Jiménez de Anta M. T. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol. 1997 Apr;26(4):787–793. doi: 10.1016/s0168-8278(97)80243-7. [DOI] [PubMed] [Google Scholar]
  21. Sáiz J. C., Sans M., Mas A., Olmedo E., Forns X., López-Labrador F. X., Restrepo J. C., Costa J., Salmerón J. M., Guilera M. Hepatitis G virus infection in fulminant hepatic failure. Gut. 1997 Nov;41(5):696–699. doi: 10.1136/gut.41.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sánchez-Tapias J. M., Forns X., Ampurdanés S., Titó L., Planas R., Viver J. M., Acero D., Torres M., Mas P., Morillas R. Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial. Gut. 1996 Apr;38(4):603–609. doi: 10.1136/gut.38.4.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tagariello G., Infantolino D., Biasin M. R., Davoli P. G., Traldi A. Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection. Lancet. 1996 Sep 14;348(9029):760–761. doi: 10.1016/S0140-6736(05)65677-2. [DOI] [PubMed] [Google Scholar]
  24. Tameda Y., Kosaka Y., Tagawa S., Takase K., Sawada N., Nakao H., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol. 1996 Dec;25(6):842–847. doi: 10.1016/s0168-8278(96)80287-x. [DOI] [PubMed] [Google Scholar]
  25. Tanaka E., Alter H. J., Nakatsuji Y., Shih J. W., Kim J. P., Matsumoto A., Kobayashi M., Kiyosawa K. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 1996 Nov 1;125(9):740–743. doi: 10.7326/0003-4819-125-9-199611010-00007. [DOI] [PubMed] [Google Scholar]
  26. Yoshiba M., Okamoto H., Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 1995 Oct 28;346(8983):1131–1132. doi: 10.1016/s0140-6736(95)91802-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES